Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.76 USD 1.47% Market Closed
Market Cap: 815.2m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Accounts Payable
$25.5m
CAGR 3-Years
53%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Accounts Payable
CA$2.7m
CAGR 3-Years
21%
CAGR 5-Years
56%
CAGR 10-Years
36%
Replicel Life Sciences Inc
XTSX:RP
Accounts Payable
CA$391.4k
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
0%
Innovotech Inc
XTSX:IOT
Accounts Payable
CA$130.2k
CAGR 3-Years
23%
CAGR 5-Years
14%
CAGR 10-Years
-14%
No Stocks Found

Abcellera Biologics Inc
Glance View

Market Cap
802.7m USD
Industry
Life Sciences Tools & Services

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
1.67 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is Abcellera Biologics Inc's Accounts Payable?
Accounts Payable
25.5m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Accounts Payable amounts to 25.5m USD.

What is Abcellera Biologics Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
76%

Over the last year, the Accounts Payable growth was 72%. The average annual Accounts Payable growth rates for Abcellera Biologics Inc have been 53% over the past three years , 76% over the past five years .

Back to Top